Microglial dysfunction in brain aging and Alzheimer's disease
about
Microglial Priming and Alzheimer's Disease: A Possible Role for (Early) Immune Challenges and Epigenetics?Toward more predictive genetic mouse models of Alzheimer's diseaseAlzheimer's Disease: Mechanism and Approach to Cell TherapyImplications of glial nitric oxide in neurodegenerative diseasesSTIM and ORAI proteins in the nervous systemMicroglial cell dysregulation in brain aging and neurodegenerationThe choreography of neuroinflammation in Huntington's diseaseMicroglial pathologyNeuroimmune and Neuropathic Responses of Spinal Cord and Dorsal Root Ganglia in Middle AgeStress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug.Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat strokeAgeing, neurodegeneration and brain rejuvenationMicroglia communication: Parallels between aging and Alzheimer's diseasePorphyromonas gingivalis Periodontal Infection and Its Putative Links with Alzheimer's DiseaseAmphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicityChronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.Transcriptomic evidence of a para-inflammatory state in the middle aged lumbar spinal cord.Microglia change from a reactive to an age-like phenotype with the time in cultureAltered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2.Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk.Stem cell models of Alzheimer's disease: progress and challenges.Age-Related Decline in the Variation of Dynamic Functional Connectivity: A Resting State AnalysisTarget engagement analysis and link to pharmacodynamic endpoint for a novel class of CNS-penetrant and efficacious p38α MAPK inhibitors.Aging reduces glial uptake and promotes extracellular accumulation of Aβ from a lentiviral vector.A comprehensive multiomics approach toward understanding the relationship between aging and dementia.Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease.Nuclear receptors in neurodegenerative diseases.The sleep-wake cycle and Alzheimer's disease: what do we know?Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexThe evolving biology of microglia in Alzheimer's disease.Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microgliaCharacterizing newly repopulated microglia in the adult mouse: impacts on animal behavior, cell morphology, and neuroinflammation.Closed head injury in an age-related Alzheimer mouse model leads to an altered neuroinflammatory response and persistent cognitive impairment.Microglial Kv1.3 Channels and P2Y12 Receptors Differentially Regulate Cytokine and Chemokine Release from Brain Slices of Young Adult and Aged Mice.Therapeutic potential of mGluR5 targeting in Alzheimer's diseaseDisease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging.Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain.
P2860
Q26739495-D22D3A2D-BC7E-4079-AD96-9C40F917B40AQ26771883-592D780C-5DA5-4C31-9EDD-96A2DB153322Q26778149-3279D85B-56D3-439D-B2C0-99894A1E6D10Q26782894-FF988579-7710-40AF-8DE3-61CD4F1E38FCQ26798378-9F56F7D1-DB61-41D4-B334-89089547AC23Q26800212-19D32862-0E0F-4F93-BE6E-8BDFEA3517C2Q26828403-0C0192F9-0D94-43D2-A3E9-0B5ED578DC0AQ26992285-52BA0145-61DC-427C-B15D-76CBD6282041Q27301286-57325408-C7F8-4EDB-A411-939A40983DA1Q27311810-38513BD1-627C-4107-AE5B-94DFFD34F947Q27322384-6078C590-8EC7-4612-8FFE-E75D01B78CABQ28066324-BAF574AF-FC51-47DA-90C3-D5B0A6F262ACQ28071590-BF1892F3-23C5-4ADA-BE20-C2C3D643FFE5Q28074099-67E133E2-AFD7-489B-BA1B-385F5C30EAEBQ28083786-BED9A384-9A21-4E42-BCA6-48DB8623774EQ28388234-FEFB4DAA-5E50-4E80-A9E7-94FA458F133CQ30829817-75635722-E685-49B0-9A01-0D46A199DDBCQ33560701-1727F6AD-ED7A-4E5C-9851-C374CB1620D9Q33695687-4BD0317F-8369-43A2-B760-DDDD57DF5C43Q33727947-8D51BD3D-05B1-4DCB-8107-BAEBD3939C21Q33733863-DBE701F3-AAFA-41D9-8DA8-DC7EE5F21CF8Q33796378-282B92F0-91EC-441F-9C76-ABFC8DCB6DCFQ33854480-D2067394-5A28-4EDF-A021-A3746AC709D3Q34006977-8EE298B2-69FC-4B3E-82F8-EC7A90DD6B75Q34048670-1AEC073D-5620-4CA3-B048-D7B12F10D52EQ34501570-77F4BBC0-9C35-430E-8818-87D35DD66637Q34545200-E849E0EB-25EB-401C-89C0-FF017196159FQ34580020-033A0400-2CE1-4450-A56A-DBC3465B7EB2Q34637928-7AB987A2-430F-4450-8822-1AC7FBD901C6Q34933261-9693E7B8-D867-4C23-842F-FCA903C6CDDAQ35044486-CCF4007D-27F1-4C03-B203-7292A8AC4A23Q35064995-FFFB02FF-71CE-4578-922C-99DFC3F1752BQ35132340-A97813E8-1957-4232-B0B8-6D7DCE727952Q35272389-3EFAC67A-8F95-4346-989F-35ACF001A6D6Q35301791-CCDD1818-970C-4A36-BEEE-B4EF0233EA7DQ35515670-5B663894-1443-43E3-A17B-65ED280C56D3Q35641919-52906A47-71B6-4A0D-84CB-B27A14F093F3Q35698522-4A4509A9-EBC7-4B79-ADF0-FB0CE9A0092BQ35809944-A99214C1-49F7-46D3-BA2F-A80503C317CDQ35889023-3726EAE9-AFE8-4DE0-9EC2-C7786AE5469C
P2860
Microglial dysfunction in brain aging and Alzheimer's disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Microglial dysfunction in brain aging and Alzheimer's disease
@en
Microglial dysfunction in brain aging and Alzheimer's disease.
@nl
type
label
Microglial dysfunction in brain aging and Alzheimer's disease
@en
Microglial dysfunction in brain aging and Alzheimer's disease.
@nl
prefLabel
Microglial dysfunction in brain aging and Alzheimer's disease
@en
Microglial dysfunction in brain aging and Alzheimer's disease.
@nl
P2860
P1476
Microglial dysfunction in brain aging and Alzheimer's disease
@en
P2093
Tony Wyss-Coray
P2860
P304
P356
10.1016/J.BCP.2014.01.008
P407
P577
2014-01-18T00:00:00Z